BWV | Blue Water Vaccines, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.1776 - 0.2000
52 Week Range	0.1601 - 1.9500
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	520,290
Average Volume	435,531
Shares Outstanding	18,903,700
Market Cap	3,406,447
Sector	Healthcare
Industry	Biotechnology
IPO Date	2022-02-18

Valuation
Profitability
Growth
Health
P/E Ratio	-0.17
Forward P/E Ratio	N/A
EPS	-1.08
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	12
Country	USA
Website	BWV

Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.

BWV's peers: ADTX, AIM, COCP, ENSC, GOVX, HOTH, INDP, KPRX, KTTA, LGVN, NRBO, NRSN, PYPD, QLGN, QNRX, REVB, SIDU, SPRC, TCBP, TENX, VRPX, VRAX, CMND

*Chart delayed

Analyzing fundamentals for BWV we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see BWV Fundamentals page.

Watching at BWV technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on BWV Technicals page.